CIR Support For Ingredient Immune, Hormonal Effects Screening Urged
This article was originally published in The Rose Sheet
Executive Summary
Cosmetic ingredient screening data on immune suppression and enhancement effects on skin should become a more regular element of safety assessments conducted by the Cosmetic Ingredient Review Expert Panel in the future, outgoing panelist Arnold Schroeter, MD, said at a CIR meeting in Washington, D.C. June 4-5.
You may also be interested in...
EU industry association
European Federation for Cosmetic Ingredients trade association launches Sept. 1 as French (FPS/COVREC) and German (TEGEWA/Sector group) associations responsible for the manufacturing, testing and marketing of cosmetics join forces to "create a structure of a European size." The European Federation includes 60 member companies, representing 80%-90% of their sector and sales of $616 mil. ([Euro]700 mil.). Spain, Italy and the U.K. have been invited to join the European Federation, which will work in partnership with Colipa and CTFA
EU Liaison To CIR Among Changes Planned To Strengthen Panel
The Cosmetic Ingredient Review Expert Panel plans to add a representative from the European Union as part of a program designed to strengthen the CIR process. The EU liaison is expected to improve communication regarding international harmonization and help FDA to implement the harmonization requirements of the FDA Modernization Act.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program